The Athinoula A. Martinos Center is committed to developing novel techniques for imaging biological systems and biologically relevant materials, and to applying these techniques toward a more comprehensive understanding and better care of the human mind and body.
The Hooker Research Group, part of the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, focuses on the development and application of in vivo molecular imaging tools.
The Breast Imaging Research program at the Massachusetts General Hospital Department of Radiology is dedicated to improving breast cancer detection and diagnosis in order to reduce the death rate of breast cancer.
The Cardiac MR PET CT Program at Massachusetts General Hospital is dedicated to developing, evaluating and assessing novel imaging techniques for cardiovascular conditions.
The Cardiovascular Imaging Core Lab at Massachusetts General Hospital is an independent facility dedicated to providing the highest quality services to the cardiovascular imaging community.
The Center for Molecular Imaging Research (CMIR) at Massachusetts General Hospital and Harvard Medical School researches molecular phenomena in order to develop novel sensing technologies and, ultimately, clinical applications that can save lives.
The Institute for Technology Assessment (ITA) conducts health outcomes research to guide the development, evaluation and utilization of medical technologies that improve the quality and cost-effectiveness of medical care.
Mass General Imaging's Global Health Programs are dedicated to addressing unmet medical imaging needs and healthcare disparities for vulnerable and crisis-affected populations.
The Massachusetts General Hospital Imaging Trials Center (MITC) is an Academic Research Organization (ARO) that enhances clinical imaging research by providing scientific and informatics expertise to foster, design, conduct, and support clinical trials.
The MGH Metabolic Imaging Core provides investigators with streamlined access to non-invasive metabolic imaging.
NNMI encompasses Clinical Service, Education and Research and the MGH PET Core. The research areas are organized into three Centers of excellence: PET Radiochemistry Discovery (CPRD); Advanced Radiological Sciences (CARS); and Translational Nuclear Medicine and Molecular Imaging (CTNMI)
Drs. Vaina and Buonanno's Neurology of Vision Lab links stroke neurology to neuroscience and multimodal brain imaging, to offer diagnosis and treatment of disorders of the brain affecting visual perception and cognition.
With faculty members from the departments of Neurology, Radiology, Pediatrics, and Anesthesia and Critical Care, the Neuroscience Center works to understand the biology of neurological disorders and develop novel methods of diagnosis and treatment.
The PET (positron emission tomography) Core Laboratory provides a full range of technical and professional services for the design and execution of programs using PET.
The Radiochemistry Program - Vasdev Lab at Massachusetts General Hospital is dedicated to discovering new chemistry and evaluating novel PET radiopharmaceuticals for preclinical and clinical imaging studies.
The Stem Cell Therapeutics and Imaging Program in the Department of Radiology at Massachusetts General Hospital focuses on engineering therapeutic and diagnostic stem cells for different pathologies in pre-clinical settings and translating them into clinics.
MIDA is an interdisiplinary collaborative center for the purpose of basic science and clinical research of prescription drug abuse.
The Tumor Imaging Metrics Core (TIMC) provides standardized, consistent, and efficient radiological measurements to evaluate tumor response for DF/HCC (Dana-Farber /Harvard Cancer Center) clinical trials.
The Webster Center promotes and develops imaging methods that use the lowest achievable radiological exposure to patients and disseminates those methods through dedicated radiation-dose education programs.